Literature DB >> 15910564

Melatonin, the pineal gland and their implications for headache disorders.

M F P Peres1.   

Abstract

There is now evidence that melatonin may have a role in the biological regulation of circadian rhythms, sleep, mood, and ageing. Altered melatonin levels in cluster headache and migraine have been documented. Melatonin mechanisms are related to headache pathophysiology in many ways, including its anti-inflammatory effect, toxic free radical scavenging, reduction of proinflammatory cytokine up-regulation, nitric oxide synthase activity and dopamine release inhibition, membrane stabilization, GABA and opioid analgesia potentiation, glutamate neurotoxicity protection, neurovascular regulation, serotonin modulation, and the similarity of chemical structure to that of indomethacin. Treatment of headache disorders with melatonin and other chronobiotic agents is promising. A double-blind, placebo-controlled trial shows melatonin is effective in cluster headache prevention, other studies also show benefit in other disorders. Melatonin plays an important role in headache disorders, offering new avenues for studying their pathophysiology and treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910564     DOI: 10.1111/j.1468-2982.2005.00889.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  27 in total

1.  Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study.

Authors:  Maria Esposito; Marco Carotenuto
Journal:  Neurol Sci       Date:  2010-09-25       Impact factor: 3.307

Review 2.  It IS a tumor -- current review of headache and brain tumor.

Authors:  Kevin Kahn; Alan Finkel
Journal:  Curr Pain Headache Rep       Date:  2014-06

Review 3.  Cluster Headache Is in Part a Disorder of the Circadian System.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

Review 4.  Role of melatonin in the pathophysiology of migraine: implications for treatment.

Authors:  Barbara Vogler; Alan M Rapoport; Stewart J Tepper; Fred Sheftell; Marcelo E Bigal
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

Authors:  Fabiano C Tanuri; Eliângela de Lima; Mario F P Peres; Francisco R Cabral; Maria da Graça Naffah-Mazzacoratti; Esper Abrão Cavalheiro; José Cipolla-Neto; Eliova Zukerman; Débora Amado
Journal:  J Headache Pain       Date:  2009-01-27       Impact factor: 7.277

6.  Melatonin to prevent migraine or tension-type headache in children.

Authors:  Silvia Miano; Pasquale Parisi; Andrea Pelliccia; Anna Luchetti; Maria Chiara Paolino; Maria Pia Villa
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

7.  Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.

Authors:  Marco Carotenuto; Maria Esposito
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

8.  Low urinary 6-sulphatoxymelatonin concentrations in acute migraine.

Authors:  Marcelo Rodrigues Masruha; Domingos Sávio de Souza Vieira; Thais Soares Cianciarullo Minett; José Cipolla-Neto; Eliova Zukerman; Luiz Celso Pereira Vilanova; Mario Fernando Prieto Peres
Journal:  J Headache Pain       Date:  2008-07-02       Impact factor: 7.277

Review 9.  Neuroendocrine dysfunction in fibromyalgia and migraine.

Authors:  Marcelo Moraes Valença; Fabíola Lys Medeiros; Hugo A Martins; Rodrigo Meirelles Massaud; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2009-10

10.  Impact of primary headaches on subjective sleep parameters among adolescents.

Authors:  Ravi Gupta; Manjeet Singh Bhatia; Devendra Dahiya; Sameer Sharma; Rahul Sapra; Kapil Semalti; Raman Preet Singh Dua
Journal:  Ann Indian Acad Neurol       Date:  2008-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.